MAPT and Cognitive impairment: The role of the amyloid burden in cognitive decline is increasingly recognized as a multi-step biological cascade, whereby a series of pathophysiological events, including tau deposition, neuronal dysfunction, and synaptic loss, are triggered in individuals with high amyloid burden, leading to cognitive impairment [8].